nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—DRD2—obesity	0.228	0.564	CbGaD
Droperidol—HTR2A—obesity	0.176	0.436	CbGaD
Droperidol—ADRA1A—Phendimetrazine—obesity	0.154	0.403	CbGbCtD
Droperidol—ADRA1A—Benzphetamine—obesity	0.117	0.305	CbGbCtD
Droperidol—ADRA1A—Phenylpropanolamine—obesity	0.111	0.291	CbGbCtD
Droperidol—Dysphoria—Methamphetamine—obesity	0.00674	0.0602	CcSEcCtD
Droperidol—Dysphoria—Phenylpropanolamine—obesity	0.00506	0.0452	CcSEcCtD
Droperidol—Dysphoria—Phentermine—obesity	0.00484	0.0432	CcSEcCtD
Droperidol—Dysphoria—Diethylpropion—obesity	0.00421	0.0376	CcSEcCtD
Droperidol—HTR2A—sympathetic nervous system—obesity	0.00315	0.144	CbGeAlD
Droperidol—HTR2A—vagus nerve—obesity	0.00305	0.14	CbGeAlD
Droperidol—Galactorrhoea—Cimetidine—obesity	0.00267	0.0239	CcSEcCtD
Droperidol—Blood pressure increased—Phendimetrazine—obesity	0.00256	0.0229	CcSEcCtD
Droperidol—Blood pressure increased—Phenylpropanolamine—obesity	0.00219	0.0195	CcSEcCtD
Droperidol—Tardive dyskinesia—Bupropion—obesity	0.00217	0.0194	CcSEcCtD
Droperidol—HTR2A—autonomic nervous system—obesity	0.00211	0.097	CbGeAlD
Droperidol—Dysphoria—Bupropion—obesity	0.00187	0.0167	CcSEcCtD
Droperidol—Blood pressure increased—Diethylpropion—obesity	0.00182	0.0163	CcSEcCtD
Droperidol—Sudden death—Sibutramine—obesity	0.00181	0.0162	CcSEcCtD
Droperidol—Altered state of consciousness—Bupropion—obesity	0.00175	0.0156	CcSEcCtD
Droperidol—Akathisia—Sibutramine—obesity	0.00167	0.0149	CcSEcCtD
Droperidol—Gynaecomastia—Diethylpropion—obesity	0.00163	0.0146	CcSEcCtD
Droperidol—Muscle rigidity—Bupropion—obesity	0.00158	0.0141	CcSEcCtD
Droperidol—Gynaecomastia—Cimetidine—obesity	0.00155	0.0139	CcSEcCtD
Droperidol—Akathisia—Bupropion—obesity	0.00146	0.013	CcSEcCtD
Droperidol—Cardiac arrest—Phentermine—obesity	0.00145	0.0129	CcSEcCtD
Droperidol—Inappropriate antidiuretic hormone secretion—Bupropion—obesity	0.00139	0.0124	CcSEcCtD
Droperidol—ADRA1A—hindbrain—obesity	0.00138	0.0632	CbGeAlD
Droperidol—DRD2—hindbrain—obesity	0.00135	0.0619	CbGeAlD
Droperidol—Torsade de pointes—Sibutramine—obesity	0.00132	0.0118	CcSEcCtD
Droperidol—Drowsiness—Phenylpropanolamine—obesity	0.00122	0.0109	CcSEcCtD
Droperidol—Palpitations—Methamphetamine—obesity	0.00113	0.0101	CcSEcCtD
Droperidol—Altered state of consciousness—Topiramate—obesity	0.00111	0.00995	CcSEcCtD
Droperidol—Hallucination—Phenylpropanolamine—obesity	0.00109	0.00977	CcSEcCtD
Droperidol—Amenorrhoea—Orlistat—obesity	0.00109	0.00973	CcSEcCtD
Droperidol—Palpitations—Benzphetamine—obesity	0.00109	0.0097	CcSEcCtD
Droperidol—Extrapyramidal disorder—Bupropion—obesity	0.00107	0.00958	CcSEcCtD
Droperidol—Amenorrhoea—Sibutramine—obesity	0.00105	0.00941	CcSEcCtD
Droperidol—Hallucination—Phentermine—obesity	0.00105	0.00935	CcSEcCtD
Droperidol—Drowsiness—Diethylpropion—obesity	0.00102	0.0091	CcSEcCtD
Droperidol—Tachycardia—Methamphetamine—obesity	0.00102	0.00907	CcSEcCtD
Droperidol—Palpitations—Phendimetrazine—obesity	0.00099	0.00884	CcSEcCtD
Droperidol—Tachycardia—Benzphetamine—obesity	0.000979	0.00874	CcSEcCtD
Droperidol—Drowsiness—Cimetidine—obesity	0.00097	0.00866	CcSEcCtD
Droperidol—Blood pressure increased—Sibutramine—obesity	0.000926	0.00827	CcSEcCtD
Droperidol—Ventricular tachycardia—Sibutramine—obesity	0.000926	0.00827	CcSEcCtD
Droperidol—Amenorrhoea—Bupropion—obesity	0.000919	0.00821	CcSEcCtD
Droperidol—Tachycardia—Phendimetrazine—obesity	0.000892	0.00797	CcSEcCtD
Droperidol—HTR2A—hindbrain—obesity	0.000891	0.0408	CbGeAlD
Droperidol—Hallucination—Cimetidine—obesity	0.000866	0.00774	CcSEcCtD
Droperidol—KCNH2—islet of Langerhans—obesity	0.000861	0.0395	CbGeAlD
Droperidol—DRD2—respiratory system—obesity	0.000825	0.0378	CbGeAlD
Droperidol—Anxiety—Phenylpropanolamine—obesity	0.000812	0.00725	CcSEcCtD
Droperidol—Palpitations—Phentermine—obesity	0.000809	0.00723	CcSEcCtD
Droperidol—Blood pressure increased—Bupropion—obesity	0.000808	0.00721	CcSEcCtD
Droperidol—Hypertension—Phentermine—obesity	0.00079	0.00706	CcSEcCtD
Droperidol—Hypersensitivity—Methamphetamine—obesity	0.000766	0.00684	CcSEcCtD
Droperidol—Tachycardia—Phenylpropanolamine—obesity	0.000762	0.00681	CcSEcCtD
Droperidol—Hypersensitivity—Benzphetamine—obesity	0.000739	0.0066	CcSEcCtD
Droperidol—Hypotension—Phenylpropanolamine—obesity	0.00073	0.00652	CcSEcCtD
Droperidol—Tachycardia—Phentermine—obesity	0.000729	0.00651	CcSEcCtD
Droperidol—Gynaecomastia—Bupropion—obesity	0.000723	0.00645	CcSEcCtD
Droperidol—Palpitations—Diethylpropion—obesity	0.000704	0.00629	CcSEcCtD
Droperidol—Somnolence—Phenylpropanolamine—obesity	0.000694	0.0062	CcSEcCtD
Droperidol—Dizziness—Methamphetamine—obesity	0.000688	0.00614	CcSEcCtD
Droperidol—Anxiety—Diethylpropion—obesity	0.000676	0.00603	CcSEcCtD
Droperidol—Dizziness—Benzphetamine—obesity	0.000663	0.00592	CcSEcCtD
Droperidol—ADRA1A—cardiovascular system—obesity	0.000644	0.0296	CbGeAlD
Droperidol—Anxiety—Cimetidine—obesity	0.000643	0.00574	CcSEcCtD
Droperidol—Cardiac arrest—Sibutramine—obesity	0.000639	0.00571	CcSEcCtD
Droperidol—Tachycardia—Diethylpropion—obesity	0.000634	0.00567	CcSEcCtD
Droperidol—KCNH2—cardiovascular system—obesity	0.000622	0.0285	CbGeAlD
Droperidol—Anaphylactic shock—Cimetidine—obesity	0.000619	0.00552	CcSEcCtD
Droperidol—Dizziness—Phendimetrazine—obesity	0.000604	0.0054	CcSEcCtD
Droperidol—Tachycardia—Cimetidine—obesity	0.000604	0.00539	CcSEcCtD
Droperidol—Bronchospasm—Orlistat—obesity	0.000591	0.00527	CcSEcCtD
Droperidol—Amenorrhoea—Topiramate—obesity	0.000586	0.00523	CcSEcCtD
Droperidol—Somnolence—Diethylpropion—obesity	0.000578	0.00516	CcSEcCtD
Droperidol—Hypersensitivity—Phenylpropanolamine—obesity	0.000575	0.00514	CcSEcCtD
Droperidol—ADRA1A—adipose tissue—obesity	0.000568	0.0261	CbGeAlD
Droperidol—DRD2—pituitary gland—obesity	0.000559	0.0256	CbGeAlD
Droperidol—KCNH2—pituitary gland—obesity	0.000551	0.0253	CbGeAlD
Droperidol—Somnolence—Cimetidine—obesity	0.00055	0.00491	CcSEcCtD
Droperidol—HTR2A—respiratory system—obesity	0.000544	0.0249	CbGeAlD
Droperidol—Depression—Orlistat—obesity	0.000534	0.00477	CcSEcCtD
Droperidol—Hyperglycaemia—Sibutramine—obesity	0.000524	0.00468	CcSEcCtD
Droperidol—Depression—Sibutramine—obesity	0.000517	0.00461	CcSEcCtD
Droperidol—Dizziness—Phenylpropanolamine—obesity	0.000516	0.00461	CcSEcCtD
Droperidol—ADRA1A—adrenal gland—obesity	0.00051	0.0234	CbGeAlD
Droperidol—Bronchospasm—Bupropion—obesity	0.000498	0.00445	CcSEcCtD
Droperidol—Dizziness—Phentermine—obesity	0.000494	0.00441	CcSEcCtD
Droperidol—Rash—Phenylpropanolamine—obesity	0.000492	0.0044	CcSEcCtD
Droperidol—KCNH2—adrenal gland—obesity	0.000492	0.0226	CbGeAlD
Droperidol—Dermatitis—Phenylpropanolamine—obesity	0.000492	0.00439	CcSEcCtD
Droperidol—Body temperature increased—Cimetidine—obesity	0.000489	0.00437	CcSEcCtD
Droperidol—Rash—Phentermine—obesity	0.000471	0.00421	CcSEcCtD
Droperidol—Dermatitis—Phentermine—obesity	0.000471	0.0042	CcSEcCtD
Droperidol—Hyperglycaemia—Bupropion—obesity	0.000457	0.00408	CcSEcCtD
Droperidol—Hypersensitivity—Cimetidine—obesity	0.000456	0.00407	CcSEcCtD
Droperidol—ADRA1A—endocrine gland—obesity	0.000442	0.0203	CbGeAlD
Droperidol—DRD2—endocrine gland—obesity	0.000433	0.0199	CbGeAlD
Droperidol—Dizziness—Diethylpropion—obesity	0.00043	0.00384	CcSEcCtD
Droperidol—KCNH2—endocrine gland—obesity	0.000427	0.0196	CbGeAlD
Droperidol—Chills—Sibutramine—obesity	0.000417	0.00373	CcSEcCtD
Droperidol—HTR2A—cardiovascular system—obesity	0.000417	0.0191	CbGeAlD
Droperidol—Rash—Diethylpropion—obesity	0.00041	0.00366	CcSEcCtD
Droperidol—Dermatitis—Diethylpropion—obesity	0.00041	0.00366	CcSEcCtD
Droperidol—Dizziness—Cimetidine—obesity	0.000409	0.00365	CcSEcCtD
Droperidol—Hallucination—Bupropion—obesity	0.000403	0.0036	CcSEcCtD
Droperidol—ADRA1A—liver—obesity	0.000399	0.0183	CbGeAlD
Droperidol—Rash—Cimetidine—obesity	0.00039	0.00348	CcSEcCtD
Droperidol—Dermatitis—Cimetidine—obesity	0.00039	0.00348	CcSEcCtD
Droperidol—Angioedema—Orlistat—obesity	0.000382	0.00341	CcSEcCtD
Droperidol—Fluspirilene—ADRB1—obesity	0.000378	0.108	CrCbGaD
Droperidol—Angioedema—Sibutramine—obesity	0.00037	0.0033	CcSEcCtD
Droperidol—Palpitations—Orlistat—obesity	0.00037	0.0033	CcSEcCtD
Droperidol—HTR2A—pituitary gland—obesity	0.000369	0.0169	CbGeAlD
Droperidol—Chills—Bupropion—obesity	0.000364	0.00325	CcSEcCtD
Droperidol—Syncope—Sibutramine—obesity	0.000363	0.00324	CcSEcCtD
Droperidol—Palpitations—Sibutramine—obesity	0.000358	0.0032	CcSEcCtD
Droperidol—Loss of consciousness—Sibutramine—obesity	0.000356	0.00318	CcSEcCtD
Droperidol—Anxiety—Orlistat—obesity	0.000355	0.00317	CcSEcCtD
Droperidol—Hypertension—Sibutramine—obesity	0.00035	0.00312	CcSEcCtD
Droperidol—HTR2A—digestive system—obesity	0.000346	0.0159	CbGeAlD
Droperidol—Anxiety—Sibutramine—obesity	0.000344	0.00307	CcSEcCtD
Droperidol—Anaphylactic shock—Orlistat—obesity	0.000341	0.00305	CcSEcCtD
Droperidol—Anaphylactic shock—Sibutramine—obesity	0.00033	0.00295	CcSEcCtD
Droperidol—HTR2A—adrenal gland—obesity	0.00033	0.0151	CbGeAlD
Droperidol—Haloperidol—DRD4—obesity	0.000328	0.0934	CrCbGaD
Droperidol—Shock—Sibutramine—obesity	0.000325	0.0029	CcSEcCtD
Droperidol—Angioedema—Bupropion—obesity	0.000323	0.00288	CcSEcCtD
Droperidol—Tachycardia—Sibutramine—obesity	0.000323	0.00288	CcSEcCtD
Droperidol—Syncope—Bupropion—obesity	0.000317	0.00283	CcSEcCtD
Droperidol—Palpitations—Bupropion—obesity	0.000312	0.00279	CcSEcCtD
Droperidol—Loss of consciousness—Bupropion—obesity	0.00031	0.00277	CcSEcCtD
Droperidol—Hypotension—Sibutramine—obesity	0.000309	0.00276	CcSEcCtD
Droperidol—Hypertension—Bupropion—obesity	0.000305	0.00272	CcSEcCtD
Droperidol—Anxiety—Bupropion—obesity	0.0003	0.00267	CcSEcCtD
Droperidol—Somnolence—Sibutramine—obesity	0.000294	0.00262	CcSEcCtD
Droperidol—Haloperidol—HTR1B—obesity	0.000291	0.083	CrCbGaD
Droperidol—Hyperglycaemia—Topiramate—obesity	0.000291	0.0026	CcSEcCtD
Droperidol—Fluspirilene—SLC6A4—obesity	0.000288	0.0821	CrCbGaD
Droperidol—Anaphylactic shock—Bupropion—obesity	0.000288	0.00257	CcSEcCtD
Droperidol—Depression—Topiramate—obesity	0.000287	0.00256	CcSEcCtD
Droperidol—Fluspirilene—DRD2—obesity	0.000287	0.0817	CrCbGaD
Droperidol—HTR2A—endocrine gland—obesity	0.000286	0.0131	CbGeAlD
Droperidol—Shock—Bupropion—obesity	0.000283	0.00253	CcSEcCtD
Droperidol—Tachycardia—Bupropion—obesity	0.000281	0.00251	CcSEcCtD
Droperidol—Haloperidol—DRD1—obesity	0.000278	0.079	CrCbGaD
Droperidol—Body temperature increased—Orlistat—obesity	0.00027	0.00241	CcSEcCtD
Droperidol—Hypotension—Bupropion—obesity	0.000269	0.0024	CcSEcCtD
Droperidol—Body temperature increased—Sibutramine—obesity	0.000261	0.00233	CcSEcCtD
Droperidol—HTR2A—liver—obesity	0.000258	0.0118	CbGeAlD
Droperidol—Hallucination—Topiramate—obesity	0.000257	0.0023	CcSEcCtD
Droperidol—Domperidone—DRD2—obesity	0.000257	0.0731	CrCbGaD
Droperidol—Somnolence—Bupropion—obesity	0.000256	0.00229	CcSEcCtD
Droperidol—Hypersensitivity—Orlistat—obesity	0.000252	0.00225	CcSEcCtD
Droperidol—Fenbufen—PTGS2—obesity	0.000251	0.0714	CrCbGaD
Droperidol—Hypersensitivity—Sibutramine—obesity	0.000243	0.00217	CcSEcCtD
Droperidol—Chills—Topiramate—obesity	0.000232	0.00207	CcSEcCtD
Droperidol—Body temperature increased—Bupropion—obesity	0.000228	0.00203	CcSEcCtD
Droperidol—Dizziness—Orlistat—obesity	0.000226	0.00202	CcSEcCtD
Droperidol—Fluspirilene—HTR2A—obesity	0.000222	0.0631	CrCbGaD
Droperidol—Dizziness—Sibutramine—obesity	0.000219	0.00195	CcSEcCtD
Droperidol—Rash—Orlistat—obesity	0.000215	0.00192	CcSEcCtD
Droperidol—Dermatitis—Orlistat—obesity	0.000215	0.00192	CcSEcCtD
Droperidol—Pimozide—DRD2—obesity	0.000214	0.061	CrCbGaD
Droperidol—Hypersensitivity—Bupropion—obesity	0.000212	0.0019	CcSEcCtD
Droperidol—Rash—Sibutramine—obesity	0.000208	0.00186	CcSEcCtD
Droperidol—Dermatitis—Sibutramine—obesity	0.000208	0.00186	CcSEcCtD
Droperidol—Pimozide—CYP2E1—obesity	0.000206	0.0588	CrCbGaD
Droperidol—Syncope—Topiramate—obesity	0.000202	0.0018	CcSEcCtD
Droperidol—Palpitations—Topiramate—obesity	0.000199	0.00177	CcSEcCtD
Droperidol—Loss of consciousness—Topiramate—obesity	0.000198	0.00177	CcSEcCtD
Droperidol—Haloperidol—DRD2—obesity	0.000196	0.0557	CrCbGaD
Droperidol—Hypertension—Topiramate—obesity	0.000194	0.00173	CcSEcCtD
Droperidol—Anxiety—Topiramate—obesity	0.000191	0.0017	CcSEcCtD
Droperidol—Dizziness—Bupropion—obesity	0.000191	0.0017	CcSEcCtD
Droperidol—Rash—Bupropion—obesity	0.000182	0.00162	CcSEcCtD
Droperidol—Dermatitis—Bupropion—obesity	0.000181	0.00162	CcSEcCtD
Droperidol—Shock—Topiramate—obesity	0.000181	0.00161	CcSEcCtD
Droperidol—Tachycardia—Topiramate—obesity	0.000179	0.0016	CcSEcCtD
Droperidol—Hypotension—Topiramate—obesity	0.000172	0.00153	CcSEcCtD
Droperidol—Pimozide—HTR2A—obesity	0.000166	0.0472	CrCbGaD
Droperidol—Somnolence—Topiramate—obesity	0.000163	0.00146	CcSEcCtD
Droperidol—Haloperidol—HTR2A—obesity	0.000151	0.0431	CrCbGaD
Droperidol—Body temperature increased—Topiramate—obesity	0.000145	0.0013	CcSEcCtD
Droperidol—Hypersensitivity—Topiramate—obesity	0.000135	0.00121	CcSEcCtD
Droperidol—Dizziness—Topiramate—obesity	0.000121	0.00108	CcSEcCtD
Droperidol—Rash—Topiramate—obesity	0.000116	0.00103	CcSEcCtD
Droperidol—Dermatitis—Topiramate—obesity	0.000116	0.00103	CcSEcCtD
Droperidol—ADRA1A—Signaling Pathways—HTR2C—obesity	9.91e-06	0.000129	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3CG—obesity	9.87e-06	0.000128	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NTRK2—obesity	9.84e-06	0.000128	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRB1—obesity	9.8e-06	0.000127	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AGT—obesity	9.76e-06	0.000127	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GHRL—obesity	9.75e-06	0.000127	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PARP1—obesity	9.75e-06	0.000127	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3CG—obesity	9.71e-06	0.000126	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—DRD4—obesity	9.67e-06	0.000126	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NTRK2—obesity	9.64e-06	0.000125	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADRB1—obesity	9.6e-06	0.000125	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PARP1—obesity	9.59e-06	0.000125	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GHRL—obesity	9.59e-06	0.000125	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—DRD4—obesity	9.51e-06	0.000124	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3CG—obesity	9.51e-06	0.000123	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PARP1—obesity	9.39e-06	0.000122	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GHRL—obesity	9.39e-06	0.000122	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—POMC—obesity	9.39e-06	0.000122	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PRKCB—obesity	9.36e-06	0.000122	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—F2—obesity	9.36e-06	0.000122	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—DRD4—obesity	9.32e-06	0.000121	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—POMC—obesity	9.24e-06	0.00012	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CNR1—obesity	9.23e-06	0.00012	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PRKCB—obesity	9.21e-06	0.00012	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—F2—obesity	9.21e-06	0.00012	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CNR1—obesity	9.09e-06	0.000118	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TCF7L2—obesity	9.07e-06	0.000118	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—POMC—obesity	9.05e-06	0.000118	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AKT2—obesity	9.03e-06	0.000117	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—F2—obesity	9.02e-06	0.000117	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PRKCB—obesity	9.02e-06	0.000117	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3CG—obesity	8.96e-06	0.000116	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TCF7L2—obesity	8.92e-06	0.000116	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GCG—obesity	8.92e-06	0.000116	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PTPN1—obesity	8.92e-06	0.000116	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CNR1—obesity	8.9e-06	0.000116	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AKT2—obesity	8.88e-06	0.000115	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—DRD2—obesity	8.86e-06	0.000115	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3CG—obesity	8.82e-06	0.000115	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GCG—obesity	8.77e-06	0.000114	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PTPN1—obesity	8.77e-06	0.000114	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TCF7L2—obesity	8.74e-06	0.000114	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AKT2—obesity	8.7e-06	0.000113	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—DRD2—obesity	8.68e-06	0.000113	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3CD—obesity	8.67e-06	0.000113	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3CG—obesity	8.63e-06	0.000112	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GCG—obesity	8.59e-06	0.000112	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PTPN1—obesity	8.59e-06	0.000112	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3CD—obesity	8.54e-06	0.000111	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—POMC—obesity	8.53e-06	0.000111	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRL—obesity	8.51e-06	0.000111	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—POMC—obesity	8.39e-06	0.000109	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—STK11—obesity	8.38e-06	0.000109	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRL—obesity	8.37e-06	0.000109	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3CD—obesity	8.36e-06	0.000109	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCL2—obesity	8.35e-06	0.000108	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PLG—obesity	8.29e-06	0.000108	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—RHOA—obesity	8.28e-06	0.000108	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—STK11—obesity	8.25e-06	0.000107	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—POMC—obesity	8.22e-06	0.000107	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCL2—obesity	8.21e-06	0.000107	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AKT2—obesity	8.2e-06	0.000106	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRL—obesity	8.2e-06	0.000106	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3R1—obesity	8.19e-06	0.000106	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PLG—obesity	8.16e-06	0.000106	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—RHOA—obesity	8.14e-06	0.000106	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FOXO3—obesity	8.09e-06	0.000105	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—STK11—obesity	8.08e-06	0.000105	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADRB2—obesity	8.07e-06	0.000105	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AKT2—obesity	8.07e-06	0.000105	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3R1—obesity	8.06e-06	0.000105	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCL2—obesity	8.04e-06	0.000104	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PLG—obesity	7.99e-06	0.000104	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—RHOA—obesity	7.97e-06	0.000104	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FOXO3—obesity	7.96e-06	0.000103	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SOCS1—obesity	7.95e-06	0.000103	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRB2—obesity	7.94e-06	0.000103	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AKT2—obesity	7.9e-06	0.000103	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3R1—obesity	7.89e-06	0.000103	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3CD—obesity	7.88e-06	0.000102	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SOCS3—obesity	7.85e-06	0.000102	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SOCS1—obesity	7.82e-06	0.000102	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FOXO3—obesity	7.8e-06	0.000101	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADRB2—obesity	7.78e-06	0.000101	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3CD—obesity	7.75e-06	0.000101	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SOCS3—obesity	7.72e-06	0.0001	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GNB3—obesity	7.69e-06	9.98e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SOCS1—obesity	7.66e-06	9.95e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3CD—obesity	7.59e-06	9.86e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—TYK2—obesity	7.58e-06	9.84e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SOCS3—obesity	7.56e-06	9.83e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GNB3—obesity	7.56e-06	9.82e-05	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3CB—obesity	7.56e-06	9.82e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IGF2—obesity	7.55e-06	9.81e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—RHOA—obesity	7.52e-06	9.76e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GNAS—obesity	7.48e-06	9.72e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—TYK2—obesity	7.46e-06	9.69e-05	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3CB—obesity	7.44e-06	9.66e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3R1—obesity	7.44e-06	9.66e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IGF2—obesity	7.43e-06	9.65e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GNB3—obesity	7.4e-06	9.62e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—RHOA—obesity	7.4e-06	9.61e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GNAS—obesity	7.36e-06	9.56e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOB—obesity	7.33e-06	9.52e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3R1—obesity	7.32e-06	9.51e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—TYK2—obesity	7.3e-06	9.48e-05	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3CB—obesity	7.28e-06	9.46e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IGF2—obesity	7.27e-06	9.45e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—RHOA—obesity	7.24e-06	9.41e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOB—obesity	7.21e-06	9.37e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GNAS—obesity	7.21e-06	9.37e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3R1—obesity	7.17e-06	9.31e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCL5—obesity	7.16e-06	9.3e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOB—obesity	7.06e-06	9.17e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCL5—obesity	7.04e-06	9.15e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—LPL—obesity	7e-06	9.09e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FOXO1—obesity	6.95e-06	9.02e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RPS6KB1—obesity	6.93e-06	9.01e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCL5—obesity	6.89e-06	8.96e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—LPL—obesity	6.89e-06	8.94e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3CB—obesity	6.87e-06	8.92e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FOXO1—obesity	6.84e-06	8.88e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RPS6KB1—obesity	6.82e-06	8.86e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3CB—obesity	6.76e-06	8.78e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—LPL—obesity	6.74e-06	8.76e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FOXO1—obesity	6.69e-06	8.69e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RPS6KB1—obesity	6.68e-06	8.68e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3CB—obesity	6.62e-06	8.59e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRKCD—obesity	6.45e-06	8.37e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKCD—obesity	6.34e-06	8.24e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HTR2A—obesity	6.31e-06	8.2e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—C3—obesity	6.3e-06	8.18e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKCD—obesity	6.21e-06	8.07e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—C3—obesity	6.2e-06	8.05e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HTR2A—obesity	6.08e-06	7.9e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—C3—obesity	6.07e-06	7.88e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IRS2—obesity	5.99e-06	7.79e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AGT—obesity	5.99e-06	7.78e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IRS2—obesity	5.9e-06	7.66e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AGT—obesity	5.89e-06	7.65e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—LEP—obesity	5.87e-06	7.62e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOE—obesity	5.87e-06	7.62e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CAV1—obesity	5.81e-06	7.55e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOA1—obesity	5.8e-06	7.53e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IRS2—obesity	5.77e-06	7.5e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—LEP—obesity	5.77e-06	7.5e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOE—obesity	5.77e-06	7.5e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AGT—obesity	5.77e-06	7.49e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CAV1—obesity	5.72e-06	7.43e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOA1—obesity	5.71e-06	7.41e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—LEP—obesity	5.65e-06	7.34e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOE—obesity	5.65e-06	7.34e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ESR1—obesity	5.6e-06	7.27e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CAV1—obesity	5.6e-06	7.27e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOA1—obesity	5.59e-06	7.26e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRKCB—obesity	5.53e-06	7.19e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—F2—obesity	5.53e-06	7.19e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ESR1—obesity	5.51e-06	7.16e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—BAD—obesity	5.47e-06	7.1e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKCB—obesity	5.44e-06	7.07e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—F2—obesity	5.44e-06	7.07e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ESR1—obesity	5.4e-06	7.01e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—BAD—obesity	5.38e-06	6.99e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—F2—obesity	5.33e-06	6.92e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKCB—obesity	5.33e-06	6.92e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3CG—obesity	5.29e-06	6.88e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—BAD—obesity	5.27e-06	6.84e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IRS1—obesity	5.23e-06	6.8e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3CG—obesity	5.21e-06	6.77e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IRS1—obesity	5.15e-06	6.69e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3CG—obesity	5.1e-06	6.62e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IRS1—obesity	5.04e-06	6.55e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—POMC—obesity	5.04e-06	6.55e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—INS—obesity	5.01e-06	6.51e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—POMC—obesity	4.96e-06	6.44e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—INS—obesity	4.93e-06	6.4e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCL2—obesity	4.93e-06	6.4e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—POMC—obesity	4.85e-06	6.31e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCL2—obesity	4.85e-06	6.3e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IGF1—obesity	4.85e-06	6.3e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKT2—obesity	4.84e-06	6.29e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—INS—obesity	4.83e-06	6.27e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IGF1—obesity	4.77e-06	6.19e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKT2—obesity	4.77e-06	6.19e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCL2—obesity	4.75e-06	6.17e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IGF1—obesity	4.67e-06	6.07e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKT2—obesity	4.67e-06	6.06e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3CD—obesity	4.65e-06	6.04e-05	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3CA—obesity	4.61e-06	5.99e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SERPINE1—obesity	4.6e-06	5.98e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3CD—obesity	4.58e-06	5.95e-05	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3CA—obesity	4.54e-06	5.89e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SERPINE1—obesity	4.53e-06	5.88e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3CD—obesity	4.48e-06	5.82e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TYK2—obesity	4.48e-06	5.82e-05	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	4.44e-06	5.77e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RHOA—obesity	4.44e-06	5.77e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SERPINE1—obesity	4.43e-06	5.76e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TYK2—obesity	4.4e-06	5.72e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3R1—obesity	4.39e-06	5.71e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NOS3—obesity	4.39e-06	5.71e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RHOA—obesity	4.37e-06	5.67e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NOS3—obesity	4.32e-06	5.62e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3R1—obesity	4.32e-06	5.62e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TYK2—obesity	4.31e-06	5.6e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RHOA—obesity	4.28e-06	5.56e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3R1—obesity	4.23e-06	5.5e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NOS3—obesity	4.23e-06	5.5e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3CA—obesity	4.19e-06	5.44e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3CA—obesity	4.12e-06	5.35e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MTOR—obesity	4.06e-06	5.27e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3CB—obesity	4.06e-06	5.27e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3CA—obesity	4.03e-06	5.24e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3CB—obesity	3.99e-06	5.18e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MTOR—obesity	3.99e-06	5.18e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MTOR—obesity	3.91e-06	5.08e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3CB—obesity	3.91e-06	5.08e-05	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AKT1—obesity	3.77e-06	4.89e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6—obesity	3.71e-06	4.81e-05	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AKT1—obesity	3.7e-06	4.81e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6—obesity	3.65e-06	4.74e-05	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AKT1—obesity	3.63e-06	4.71e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6—obesity	3.57e-06	4.64e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MMP9—obesity	3.53e-06	4.58e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MMP9—obesity	3.47e-06	4.51e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAPK8—obesity	3.43e-06	4.45e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AKT1—obesity	3.42e-06	4.44e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MMP9—obesity	3.4e-06	4.41e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAPK8—obesity	3.37e-06	4.38e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AKT1—obesity	3.36e-06	4.37e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAPK8—obesity	3.3e-06	4.29e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AKT1—obesity	3.29e-06	4.28e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—STAT3—obesity	3.13e-06	4.07e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—STAT3—obesity	3.08e-06	4.01e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—STAT3—obesity	3.02e-06	3.92e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MYC—obesity	2.91e-06	3.78e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TGFB1—obesity	2.91e-06	3.77e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MYC—obesity	2.87e-06	3.72e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TGFB1—obesity	2.86e-06	3.71e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MYC—obesity	2.81e-06	3.65e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TGFB1—obesity	2.8e-06	3.64e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3CA—obesity	2.47e-06	3.21e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3CA—obesity	2.43e-06	3.16e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3CA—obesity	2.38e-06	3.09e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6—obesity	2.19e-06	2.84e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6—obesity	2.15e-06	2.8e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6—obesity	2.11e-06	2.74e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKT1—obesity	2.02e-06	2.62e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKT1—obesity	1.99e-06	2.58e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKT1—obesity	1.95e-06	2.53e-05	CbGpPWpGaD
